Endogenous glucocorticoids are essential for mobilizing energy resources, restraining inflammatory responses and coordinating behavior to an immune challenge. Impaired glucocorticoid receptor (GR) function has been associated with impaired metabolic processes, enhanced inflammation and exaggerated sickness and depressive-like behaviors. To discern the molecular mechanisms underlying GR regulation of physiologic and behavioral responses to a systemic immune challenge, GR dim mice, in which absent GR dimerization leads to impaired GR-DNA-binding-dependent mechanisms but intact GR protein-protein interactions, were administered low-dose lipopolysaccharide (LPS). GR dim -LPS mice exhibited elevated and prolonged levels of plasma corticosterone (CORT), interleukin (IL)-6 and IL-10 (but not plasma tumor necrosis factor-a (TNFa)), enhanced early expression of brain TNFa, IL-1b and IL-6 mRNA levels, and impaired later central TNFa mRNA expression. Exaggerated sickness behavior (lethargy, piloerection, ptosis) in the GR dim -LPS mice was associated with increased early brain proinflammatory cytokine expression and late plasma CORT levels, but decreased late brain TNFa expression. GR dim -LPS mice also exhibited sustained locomotor impairment in the open field, body weight loss and metabolic alterations measured by indirect calorimetry, as well as impaired thermoregulation. Taken together, these data indicate that GR dimerization-dependent DNA-binding mechanisms differentially regulate systemic and central cytokine expression in a cytokine-and time-specific manner, and are essential for the proper regulation and recovery of multiple physiologic responses to low-dose endotoxin. Moreover, these results support the concept that GR protein-protein interactions are not sufficient for glucocorticoids to exert their full anti-inflammatory effects and suggest that glucocorticoid responses limited to GR monomer-mediated transcriptional effects could predispose individuals to prolonged behavioral and metabolic sequelae of an enhanced inflammatory state.
INTRODUCTION
Endogenous glucocorticoids play an important role in regulating homeostatic processes under basal and challenge conditions, including metabolism, immune function and behavior. 1, 2 The ultimate effect of glucocorticoids is established at the level of the glucocorticoid receptor (GR). Unrestrained inflammation and hypothalamic-pituitary-adrenal (HPA) axis activity, as well as metabolic alterations, are commonly observed in certain subsets of depressed patients and may be due to glucocorticoid resistance via impaired GR function. [3] [4] [5] [6] This phenomenon may be of particular relevance to depression in the medically ill, which is characterized by an enhanced inflammatory state. [7] [8] [9] [10] Innate immune cytokines can influence virtually every pathophysiologic domain relevant to depression, including neuroendocrine function, neurotransmitter metabolism, glucose metabolism, regional brain activity and, ultimately, behavior. [11] [12] [13] Insight into the molecular mechanisms that underlie the action of GR in regulating inflammation and its behavioral and metabolic sequelae might help explain the high comorbidity between depression, metabolic disorders and chronic inflammatory disorders.
Upon exposure to an infectious or inflammatory challenge, proinflammatory cytokines, such as tumor necrosis factor-a (TNFa), interleukin (IL)-1b and IL-6, contribute to the progression of the immune response and also act on the central nervous system (CNS) to coordinate an adaptive sickness syndrome (acutephase response), which includes fever production, a characteristic set of sickness behaviors and stimulation of the HPA axis with the resultant release of glucocorticoids. [14] [15] [16] [17] Although fever is adaptive because of its antimicrobial and immunostimulating nature, it is metabolically costly. 18, 19 To conserve energy, animals shift their motivational state toward a behavioral depression, including reduced locomotor activity and food intake and increased sleep. 15 Glucocorticoids, as well as proinflammatory cytokines, facilitate the mobilization of energy sources to meet the metabolic demands associated with heat production and immune activation. 13, [20] [21] [22] Glucocorticoids also feed back on the immune system to protect the host from the detrimental consequences of an overactive inflammatory response. [23] [24] [25] [26] [27] Indeed, upon exposure to an inflammatory challenge, adrenalectomized animals or those treated with a GR antagonist exhibit exaggerated peripheral and central inflammatory responses, [28] [29] [30] [31] sickness behavior [32] [33] [34] [35] and fever, 36, 37 and in extreme cases of unresolved inflammation, septic shock-induced mortality. 38, 39 Several features of sickness behavior overlap with symptoms of depression, particularly neurovegetative symptoms (that is, psychomotor slowing, fatigue, anorexia, weight loss, hypersomnia). Sickness behavior is usually acute and considered adaptive for the recovery from infection and usually subsides along with the resolution of inflammation. However, sustained levels of inflammation can contribute to prolonged expression of these behaviors and in some conditions, culminate in the maladaptive development of depression. [8] [9] [10] [11] Similarly, the sustained catabolic effects of an enhanced inflammatory state may contribute to an 'inflammatory' metabolic syndrome. 13 Indeed, sickness behaviors/neurovegetative symptoms are a prominent feature of immunotherapy (for example, interferon-a)-induced depression and in those with metabolic syndrome. 40, 41 The molecular mechanisms by which an impaired GR may be a vulnerability factor for inflammation-induced behavioral and metabolic dysfunction requires further elucidation and is the focus of the present study.
The GR is a ligand-dependent transcription factor that belongs to the nuclear hormone receptor super family. The two main molecular pathways by which GR controls transcription are by directly binding to DNA and through protein-protein interactions with other transcription factors. Direct binding of GR to DNA includes binding to positive or negative glucocorticoid response elements (GREs) in the promoter regions of genes, leading to transcriptional increases (that is, anti-inflammatory and metabolic molecules) or decreases (that is, negative feedback on the HPA axis). Simple or 'classical' GREs consist of two palindromic GRE half-sites, separated by 3 base pairs, and are associated with GR dimerization-dependent transcription of genes. Complex GREs can include multiple GRE half-sites or GRE half-sites in conjunction with response elements for other transcription factors (composite GREs), and do not require GR dimerization. GR monomers also indirectly influence the transcription of genes through proteinprotein interactions with other transcription factors (that is, inhibiting the transcriptional activity of nuclear factor-kB and activator protein-1 on proinflammatory molecules), without binding to DNA themselves. [42] [43] [44] [45] [46] Whereas the metabolic actions of glucocorticoids are believed to be predominantly mediated by GR dimerization-dependent DNA-binding mechanisms, the extent to which these mechanisms contribute to the anti-inflammatory effects of GR remains an issue of debate. 47, 48 To dissect the relative importance of GR-DNA-binding-dependent mechanisms versus protein-protein interactions in GR regulation of the acutephase response to a systemic inflammatory challenge, we administered low-dose lipopolysaccharide (LPS) to GR dim mice, in which a point mutation in the GR-DNA-binding domain results in deficient GR dimerization. Hence, GR-DNA-binding-dependent transcriptional regulation is impaired, but GR protein-protein interactions with other transcription factors remain intact. 49 A recent study using the GR dim mice has shown that endogenous glucocorticoids require GR dimerization to effectively inhibit systemic inflammatory responses to high-dose LPS and, consequentially, GR dim mice show enhanced lethality in LPSinduced septic shock. 50 In the present study, we evaluated systemic and CNS cytokine production in GR dim mice over a 3-day time course following administration of low-dose, sublethal LPS to determine whether these mice are more susceptible to the HPA axis, inflammatory, behavioral and metabolic alterations characteristic of nonseptic inflammatory disorders. We show that GR dimerization, and hence intact GR-DNA-binding-dependent mechanisms, are essential for the proper regulation and recovery of LPS-induced corticosterone (CORT), peripheral and brain cytokines, sickness behavior and various metabolic parameters. In addition, we show that GR dimerization-dependent DNAbinding mechanisms differentially regulate systemic and central cytokine expression in a cytokine-and time-dependent manner. Taken together, these results support the concept that GR protein-protein interactions are not sufficient for glucocorticoids to exert their full anti-inflammatory effects, and suggest that endogenous glucocorticoid responses limited to GR monomermediated transcriptional effects could predispose individuals to prolonged behavioral and metabolic sequelae of an enhanced inflammatory state.
MATERIALS AND METHODS Animals
Male mice, 8-10 weeks old, were housed at the National Institutes of Health (NIH) for at least 1 week before use and were maintained on a 12 h light/dark cycle with lights on at 6:30 AM. The generation of the GR dim mice was described previously. 49 GR dim mouse breeder pairs (129 genetic background) were obtained from Dr Gü nther Schü tz (German Cancer Research Centre, Heidelberg, Germany) and breeding colonies were established at Taconic Farms (Rockville, MD, USA). 129S6.B6-Nr3c1 tm3Gsc N24 mice were generated from male and female homozygous GR dim breeder pairs. Age-matched wild-type (WT) controls (129SvEv) were purchased separately from Taconic Farms. Food and water were available ad libitum. All procedures were conducted in accordance with the NIH Guide for the Care and Use of Experimental Animals.
LPS challenge
Mice were injected intraperitoneally with either LPS (0.25 mg/kg) or sterile saline at 10 ml per g body weight. LPS (L2880; Escherichia coli, strain 055:B5; Sigma-Aldrich, St Louis, MO, USA) was reconstituted to 1 mg/ml with sterile saline. Aliquots were stored at À 80 1C until further diluted before injection. To find a sublethal dose of LPS for both genotypes, we initially tested a standard dose of LPS (1 mg/kg) known to cause upregulation of central cytokines and sickness behavior with 100% survival in normal mice. 51, 52 As in these previous studies, 100% of our WT-LPS mice survived throughout the 72-h test period. However, 0% of the GR dim -LPS mice survived after 48 h. We, therefore, chose to use a dose of 0.25 mg/kg LPS for this study, where the majority of GR dim mice survived throughout the test period (72%) and the WT mice exhibited a reliable expression of sickness behavior. Data from all mice during survival were included in analysis. Mice were killed if they reached the clinical end point of a sickness behavior score of 11 (see below).
Experimental design
Four groups of experiments were carried out in this study, each with a different set of mice. Experiment 1. Examined peripheral and central neuroendocrine and cytokine responses (plasma CORT, TNFa, IL-6 and IL-10 levels; hippocampal and hypothalamic TNFa, IL-1b, IL-6 and IL-10 mRNA; n ¼ 8-12 per group); home cage sickness behavior scores were also recorded in these mice. Hormone and cytokine assays Plasma CORT was measured by enzyme immunoassay (OCTEIA Corticosterone HS, Immunodiagnostic Systems, Fountain Hills, AZ, USA; limit of detection ¼ 0.17 ng/ml). Plasma TNFa, IL-6 and IL-10 were measured by sandwich ELISA (Quantikine murine kit, R&D Systems, Minneapolis, MN, USA; limit of detection ¼ 5.1, 1.6 and 4.0 pg/ml, respectively). Samples were run in duplicate.
Reverse transcription and real-time PCR Total RNA was isolated from the hippocampus and hypothalamus using TRIZOL (Invitrogen, Carlsbad, CA, USA), followed by DNase I treatment (Ambion-Applied Biosystems, Carlsbad, CA, USA). RNA was further purified with an RNeasy mini kit (QIAGEN, Valencia, CA, USA) and eluted in 30 ml RNase free water. Yields were determined by spectrophotometer at l 260 nm. Then, 1 mg of each RNA sample was reverse transcribed using the iScript complementary DNA Synthesis kit (Bio-Rad, Hercules, CA, USA). Real-time PCR was performed on the resulting complementary DNA using a Bio-Rad iCycler iQ for 40 cycles (denatured at 95 1C for 15 s, annealed at 55 1C for 30 s and extended at 72 1C for 30 s) and the SYBR Green PCR Master Mix (Bio-Rad). Samples were normalized to b-actin and run in duplicate. Amplifications without template were included as negative controls. Amplicon homogeneity was confirmed by melting curve analyses for all samples. The following forward (F) and reverse (R) primers were used:
Sickness parameters
Sickness behavior score. Sickness behavior was measured at 6, 24, 48 and 72 h after injection in the home cage. A total sickness behavior score was based on an 11-point system, determined by the sum of scores for three parameters: piloerection (1-3), ptosis (squinty/watery eyes; 1-4) and lethargy (1) (2) (3) (4) , with a score of 1 within each parameter considered healthy.
Body weight. Mice were weighed twice a day to collect AM and PM body weight measurements, with PM measurements taken just before lights off.
Skin temperature. The QuickTEMP non-contact thermometer (Linear Laboratories, Fremont, CA, USA) was used to measure skin temperature twice a day (AM and PM) via an infrared energy detector.
Open field: locomotor activity . Each chamber was also equipped with a two-dimensional (xy) infrared beam system (OPTO-M3, Columbus Instruments, Columbus, OH, USA) to record locomotor activity.
Telemetry
Mice were implanted intraperitoneally with telemetry transmitters (Data Sciences International, St Paul, MN, USA) to measure Tc under ambulatory conditions. All surgeries were performed under aseptic conditions and with the mice under isoflurane (inhalant) anesthesia. After a 10-day postsurgery recovery period, temperature was continuously recorded from 72 h before to 7 days after LPS administration.
Statistical analysis
Values are presented as mean ± s.e.m. A two-way analysis of variance was used to evaluate genotype (WT vs GR LPS-induced plasma cytokine responses were differentially regulated by glucocorticoids. WT and GR dim mice showed similar early rises (2 h) in plasma TNFa responses to LPS, which returned to baseline levels by 12 h (Figure 1b ). In contrast, GR dim -LPS mice exhibited increased plasma IL-6 at 2 h and prolonged elevations in plasma IL-6 and IL-10 for up to 24 h relative to WT-LPS mice (Figures 1c and d) . (Plasma cytokine levels were undetectable in saline-treated mice.) GR dim mice show exaggerated early brain inflammatory responses to LPS, but impaired later TNFa responses Out of the four cytokine transcripts measured in the brain (TNFa, IL-1b, IL-6 and IL-10), LPS-induced IL-1b mRNA was the most highly expressed in both the hippocampus and hypothalamus, the latter showing the greatest expression in both genotypes. IL-10 mRNA could not be detected in either brain region. WT expression of LPS-induced TNFa mRNA in the hippocampus and hypothalamus showed a biphasic response, where peak levels were expressed at 2 and 24 h, the latter being the time of greatest expression. TNFa mRNA responses in GR dim -LPS mice also showed a biphasic response, with the 2 h peak exceeding that of the WT, but the 24 h peak being impaired. LPS-induced IL-1b mRNA levels peaked at 2 h in the hippocampus and hypothalamus, in both genotypes, where GR dim -LPS mice showed exaggerated responses at early time points (2 and 6 h). WT expression of LPS-induced IL-6 mRNA also peaked at 2 h in the hippocampus and hypothalamus. However, GR dim -LPS mice showed peak IL-6 mRNA responses at 2 h in the hypothalamus and at 6 h in the hippocampus, exceeding WT-LPS IL-6 mRNA levels at both respective time points (Figures 2a-f ).
RESULTS

GR
GR dim mice show sustained LPS-induced sickness behavior, locomotor activity impairment and body weight loss WT-LPS mice exhibited peak expression of home cage sickness behavior (piloerection, ptosis and lethargy) and impairment in open field locomotor activity at 6 h. GR dim -LPS mice exhibited sustained sickness behavior and locomotor impairment, peaking at 24 h and showing a delayed recovery compared with WT-LPS mice (Figures 3a and b) . Interestingly, GR dim -Saline mice displayed less basal locomotor activity compared with WT-Saline mice (71% of WT). Greatest LPS-induced genotype differences occurred at 24 h (6 h: WT-62% of saline, GR dim -56% of saline; 24 h: WT-76% of saline, GR dim -38% of saline). Total sickness behavior scores positively correlated with brain cytokine expression (hippocampal and hypothalamic TNFa, IL-1b and IL-6 mRNA) at 6 h after LPS and with plasma CORT levels at later time points (12, 24 and 48 h) across both genotypes. Interestingly, sickness behavior scores were negatively correlated with hippocampal and hypothalamic expression of TNFa mRNA at 24 h after LPS across both WT and GR dim mice (Figure 4) . Under baseline conditions, saline-treated WT and GR dim mice displayed a normal circadian rhythm in their body weight, with AM increases following their active period in the dark phase and PM decreases following their inactive period in the light phase. Baseline body weights across the circadian rhythm did not differ between genotypes. In response to LPS, both WT and GR dim mice displayed a disruption in their diurnal weight patterns up to 48 h (D2-AM) (Figure 3c ). GR dim -LPS mice showed a delayed recovery in weight gain, where LPS-WT mice exhibited peak weight loss at 24 h (D1) and returned to baseline by 72 h (D3), and GR dim -LPS mice showed sustained peak weight loss up to 48 h (D2) and recovery by 96 h (D4) (Figure 3d ). GR dim mice exhibit altered metabolism and thermoregulation Substrate utilization was analyzed by indirect calorimetry. Both genotypes displayed a basal circadian rhythm in which RQ (VCO 2 / VO 2 ), TEE, carbohydrate oxidation and ambulatory activity were elevated during the active/dark phase and reduced during the inactive/light phase, whereas fat oxidation showed the reverse cycle. Genotype differences were apparent under basal conditions, where GR dim -Saline mice showed reduced VO 2 inhaled, VCO 2 exhaled, TEE, carbohydrate oxidation and ambulatory activity relative to WT-Saline mice during their inactive and active periods. RQ and fat oxidation parameters were similar under basal conditions. In response to LPS, WT mice showed reductions in RQ (decrease in both VO 2 and VCO 2 ), carbohydrate oxidation, TEE and ambulatory activity, and an increase in fat oxidation. GR dim -LPS mice showed an exacerbation of these changes, in amplitude and duration, indicating more sustained metabolic alterations. All metabolic changes were most prominent within the first 24 h (D0-PM) for both genotypes and returned to baseline by 48 h (D2-AM) in the WT-LPS mice (Figures 5a-g ).
As part of the normal circadian rhythm, Tc, as measured by telemetry, was elevated during the active/dark phase and reduced during the inactive/light phase. Before LPS injection, WT and GR dim mice exhibited similar Tc values in amplitude and circadian rhythm. A peak elevation in Tc of 1.4 1C was evident in the WT-LPS mice by 8 h after injection (still during the light phase) and returned to normal dark phase levels by 12 h after injection. In contrast, GR dim -LPS mice exhibited an early transient rise in Tc (2-4 h after injection), but were impaired in the sustained rise in Tc during the remainder of the light phase immediately following LPS injection and in the normal circadian rise of Tc during the first dark phase. GR dim -LPS mice regained their normal circadian rhythm by 24 h after injection (Figure 5h ). Basal skin temperature was the same for all groups. WT-LPS mice did not display any significant changes in skin temperature. However, GR dim mice exhibited a peak reduction in skin temperature ( À 1.6 1C) at 24 h (D1-AM) after LPS (Figure 5i ). This period of impaired thermoregulation corresponded to the time of greatest sickness behavior expression and peak impairment of locomotor activity.
DISCUSSION
We show here for the first time that mice deficient in GR dimerization, and therefore impaired in GR-DNA-binding-dependent transcriptional regulation, are more sensitive to the neuroendocrine, inflammatory, behavioral and metabolic effects of low-dose LPS. We also show for the first time that GR dimerization-dependent mechanisms differentially regulate cytokine expression in the periphery versus the brain, in a cytokineand time-dependent manner. GR dim -LPS mice exhibited elevated and prolonged levels of plasma CORT, IL-6 and IL-10 (but not plasma TNFa), enhanced early expression of brain TNFa, IL-1b and IL-6 mRNA levels and impaired later central TNFa mRNA expression. Home cage sickness behavior (lethargy, piloerection, ptosis) and impaired locomotor activity in the open field peaked later in the GR dim -LPS mice (24 h) compared with WT-LPS mice (6 h). Exaggerated sickness behavior in the GR dim -LPS mice was associated with increased early hippocampal and hypothalamic proinflammatory cytokine expression and late plasma CORT levels, but decreased late brain TNFa expression. GR dim -LPS mice also exhibited sustained body weight loss and metabolic alterations, including reduced RQ, TEE and carbohydrate oxidation, and enhanced fat oxidation compared with WT-LPS mice. Impaired thermoregulation, as evidenced by the inability to maintain a fever and normal skin temperature, was also displayed by GR dim -LPS mice. These results indicate that intact GR dimerizationdependent DNA-binding mechanisms are essential and GR monomer-mediated transcriptional effects, such as proteinprotein interactions-although may be important-are not sufficient for the proper regulation and recovery of HPA axis, inflammatory, behavioral and metabolic responses to a low-dose endotoxin challenge.
HPA axis GR negative feedback on various levels of the HPA axis is regulated by both GR dimerization-dependent and -independent mechanisms. 49 In agreement with previous studies, the GR dim mice in our study exhibited greater basal plasma CORT levels across the circadian rhythm 53 and similar early LPS-induced CORT responses compared with WT mice. 50, 54 However, in contrast to similar high-dose LPS-induced CORT responses in the GR dim and WT mice at later time points, 50 GR dim mice treated with low-dose LPS (in this study) exhibited exaggerated plasma CORT responses at later time points with a delayed return to baseline. The difference in the kinetics of the CORT response to low-versus high-dose LPS appears to be in the earlier recovery of CORT levels in the WT mice treated with low-dose LPS. A possible mechanism contributing to the sustained CORT levels observed in the GR dim mice may be their prolonged cytokine expression. 55 Indeed, LPSinduced plasma IL-6 levels were positively correlated with plasma CORT levels at 12 h, the time point when CORT responses start to diverge across both genotypes (r ¼ 0.81, Po0.001, data not shown; plasma cytokine levels were not detected in salinetreated WT or GR dim mice). These results suggest that GR dimerization-dependent DNA-binding mechanisms are required for glucocorticoid negative feedback of CORT release under basal conditions as well as for the termination of CORT responses to an LPS challenge. This sustained CORT response may be because of impaired negative feedback at the level of the HPA axis and/or cytokine production.
Inflammation
The role of glucocorticoids in keeping peripheral and central inflammatory responses in check has been well established; [23] [24] [25] [26] [27] however, the mechanism by which it does so requires further elucidation. The predominant role of GR protein-protein interactions with other transcription factors (for example, nuclear factorkB and activator protein-1) in mediating the anti-inflammatory effects of GR is mainly supported by in vitro studies. 44, 49, 54 Under in vivo conditions, the dependence of the anti-inflammatory effects of GR on GR dimerization-dependent DNA-binding mechanisms has been shown to differ according to the type of immune challenge. 50, 54, 56, 57 Our data indicate that the role of GR-DNA-binding-dependent mechanisms in regulating LPS-induced systemic inflammatory responses is cytokine specific. In agreement with previous studies using high-dose LPS, 50 the kinetic profile of low-dose LPS-induced plasma TNFa responses was similar in GR dim and WT mice. In contrast to this profile, GR dim -LPS mice (both high and low doses) exhibited greater and prolonged plasma IL-6 and IL-10 levels relative to WT-LPS mice, indicating impaired recovery in these latter cytokine responses. Our study is the first to show that GR dimerization-dependent DNA-binding mechanisms differentially regulate cytokine expression in the periphery versus the brain, and even within the brain itself. In contrast to the similar plasma TNFa levels observed in GR dim and WT-LPS mice, exaggerated hippocampal and hypothalamic TNFa mRNA expression was observed in the GR dim -LPS mice at early time points. Early expression of IL-1b and IL-6 mRNA in the brain was also exaggerated in the GR dim -LPS mice relative to WT-LPS mice. Interestingly, GR dim -LPS mice showed impaired central TNFa mRNA responses at the time when WT-LPS mice exhibited a second peak in TNFa mRNA expression (24 h ). This may be because of the exaggerated plasma CORT levels in GR dim -LPS mice at later time points, exerting a negative effect through GR dimerization-independent mechanisms. Alternatively, these data suggest that GR dimerization-dependent DNA-binding mechanisms are necessary to promote the second TNFa mRNA peak in the WT-LPS mice in the face of permissive low plasma CORT levels. A bi-phasic central TNFa mRNA response in WT-LPS mice has been shown by others, 51 where the early 2-h peak has been associated with cytokine expression in endothelial cells of the brain vasculature and the later 24-h peak with the progressive activation of intraparenchymal cells. 58 It is also possible that the second peak of TNFa in the WT-LPS mice could be anti-inflammatory and neuroprotective through TNFa binding to the TNF-R2 receptor rather than the proinflammatory TNF-R1 receptor. 59, 60 Overall, these data suggest that LPS-induced cytokine responses are tissue and time specific. Even within the same tissue (that is, the brain), different cell types and/or receptor subtypes may mediate early versus late cytokine expression. Differential transcriptional effects of glucocorticoids could be related to cell-specific expression of transcription factors, cofactors, GRE architecture as well as GR itself. 42, 44, 61, 62 Although it appears that GR monomer-mediated protein-protein interactions with other transcription factors are sufficient for keeping LPS-induced plasma TNFa responses in check, our data show that GR dimerization-dependent DNA binding mechanisms are required for glucocorticoid negative feedback on plasma IL-6 and IL-10 responses, as well as on early brain cytokine responses to LPS (TNFa, IL-1b and IL-6 mRNA). A possible mechanism for the cytokine-specific inhibition by GR dimers is their binding to negative GREs in the promoter regions of cytokine genes. 45, 63, 64 Of note, no known GRE has been identified in the TNFa promoter. 65 Alternatively, glucocorticoids upregulate the transcription of genes that inhibit cytokine mRNA stability, 42, 66, 67 and hence reduced transcription of these genes may lead to increased cytokine mRNA stability and expression. Enhanced cytokine responses in the GR dim -LPS mice could also be due to impaired upregulation of antiinflammatory molecules. 47 Because IL-10 is considered an antiinflammatory cytokine and has been shown to express a putative GRE in its promoter, 68 the greater plasma IL-10 levels in the GR dim -LPS mice were not expected. However, glucocorticoids have been shown to increase or decrease LPS-induced IL-10 secretion (in vitro), depending on glucocorticoid dose. 69 In addition, enhanced levels of IL-10 may be a compensatory mechanism for the enhanced expression of proinflammatory cytokines in the GR dim -LPS mice. The finding of undetectable levels of IL-10 mRNA expression in the brain is in agreement with studies showing that LPS-induced expression of central anti-inflammatory cytokines is limited in comparison with proinflammatory cytokine expression. 70 However, glucocorticoids have been shown to upregulate other anti-inflammatory molecules in the brain, such as IkBa and IL-1R2 receptor. 71, 72 The second wave of LPS-induced TNFa expression in the WT brain has been shown to be dependent on Toll-like receptor-2 (TLR-2) upregulation. 73 Although the inflammatory signaling of TLR activation has traditionally been associated with host defense mechanisms, TLR activation in the brain also plays a role in neuroprotection. 74, 75 Interestingly, glucocorticoids, on their own and in synergy with proinflammatory cytokines, have been shown to increase TLR2 expression. [76] [77] [78] GR-mediated transcription of TLR2 is dependent on both indirect (via another GR target gene) and direct (via a putative GRE in its proximal promoter region) mechanisms. 43, 77, 78 Therefore, the impaired central TNFa mRNA expression at 24 h in the GR dim -LPS mice might be due to reduced GR-mediated transcription of TLR-2.
Sickness behavior A functional consequence that might be predicted as a result of enhanced early proinflammatory cytokine expression in the GR dim -LPS mice is exaggerated sickness behavior.
14 Indeed, mice or rats with impaired glucocorticoid signaling, either via adrenalectomy or administration of a GR antagonist, exhibit exaggerated LPSinduced sickness behaviors (that is, reduced locomotor activity and social exploration and weight loss). 32, 33, 35 Upon LPS administration, GR dim mice in our study exhibited greater and sustained home cage sickness behavior (piloerection, ptosis and lethargy), locomotor activity impairment and weight loss relative to WT mice. Under noninflammatory conditions, previous studies have shown that impaired glucocorticoid and GR levels lead to reduced basal locomotor activity and food intake, whereas transgenic mice with impaired GR expression exhibit similar body weights compared with WT controls. [79] [80] [81] Although GR dim -Saline mice in our study displayed similar body weights compared with WT-Saline mice, as well as a normal circadian rhythm in body weight, they exhibited reduced basal locomotor activity, as measured by the open field test and an infrared beam system in the metabolic chambers (particularly in the active-PM period). This latter finding is in contrast to previous reports in the GR dim mice. 53 Differential basal behavioral phenotypes between studies may be because of differences in the genetic background of the mice. Our data suggest that GR dimerization-dependent DNA-binding mechanisms play an important role in the regulation of basal locomotor activity (at least in mice of the 129SvEv strain) and in the recovery from LPS-induced sickness behaviors. Taking into consideration the role of GR negative feedback on the expression of corticotropin-releasing hormone (CRH), altered CRH levels may contribute to reductions in locomotor activity, food intake and body weight. 82, 83 Basal levels of CRH mRNA expression in the PVN of the hypothalamus are unchanged in the GR dim mice. 49 However, hypothalamic CRH induction during an immune challenge, as well as extrahypothalamic CRH expression, have yet to be measured in the GR dim mice. In further support of the relation between exaggerated early central cytokines and behavioral responses, hippocampal and hypothalamic cytokine expression positively correlated with total sickness behavior scores at 6 h after LPS, when sickness behavior was high in both genotypes. However, at 24 h, when GR dim -LPS mice displayed peak sickness behavior and that of WT-LPS mice was already on the decline, sickness behavior scores no longer correlated with brain cytokine expression, but with plasma CORT levels. Sustained peak sickness behavior at 24 h in the GR dim -LPS mice may be because of alterations in downstream factors induced by the exaggerated early CNS cytokine response or the sustained plasma CORT response. Such factors may include changes in neurotransmitter metabolism or growth factor expression, which have been associated with depressive-like behaviors. 11, 12 If the 24-h TNFa peak in the WT-LPS mice is associated with an anti-inflammatory/neuroprotective response through TNF-R2 signaling (rather than proinflammatory TNF-R1 signaling), 59 ,60 the impaired 24-h TNFa peak in the GR dim -LPS mice may also contribute to their slower recovery in sickness behaviors. Indeed, hippocampal and hypothalamic expression of TNFa mRNA was inversely correlated with sickness behavior scores at 24 h after LPS across both genotypes, in contrast to the positive correlation at earlier time points.
Metabolism
In addition to their potent anti-inflammatory effects, glucocorticoids are known to promote a catabolic state of metabolism, providing substrates for increased liver gluconeogenesis and hence increased glucose availability and utility. 48 Previous studies have shown that GR dim mice exhibit impaired upregulation of glucocorticoid-induced transcription of liver gluconeogenic enzymes (for example, tyrosine aminotransferase), 49, 84 indicating that gluconeogenesis requires GR dimerization-dependent DNAbinding mechanisms. Using indirect calorimetry, glucocorticoids and intact GR expression have been shown to be essential for normal RQ and TEE. 79, 81 We further characterized the metabolic profile of the GR dim mice, showing reduced basal VO 2 inhaled, VCO 2 exhaled, TEE and carbohydrate oxidation relative to WTSaline mice. In contrast, there were no differences in the basal RQ (VCO 2 /VO 2 ) or fat oxidation between GR dim and WT mice. Although the GR dim -Saline mice exhibited reductions in amplitude for most metabolic parameters, their circadian rhythm was maintained. In addition to GR-DNA-bindingdependent mechanisms directly upregulating the transcription of gluconeogenic enzymes, they may indirectly regulate metabolic processes via the upregulation of catecholamine biosynthetic enzymes. Transgenic mice with impaired GR expression contain lower levels of norepinephrine in metabolically active tissues, such as brown adipose tissue. 81 Therefore, another possible mechanism by which gluconeogenesis may be impaired in the GR dim mice is through reduced sympathetic nervous system activity.
A catabolic state of metabolism can also be promoted by proinflammatory cytokines. 21 Therefore, in addition to having a direct effect on metabolic processes, impaired glucocorticoid signaling can alter metabolic pathways by enhancing inflammatory signaling. 5 In our study, both LPS-treated WT and GR dim mice showed a reduction in RQ, carbohydrate oxidation and TEE, whereas they displayed an elevation in fat oxidation, relative to saline-treated mice. A reduced RQ is indicative of an increased dependence on fat for energy metabolism in the face of reduced glucose utilization. 79 Decreased food intake (anorexia), although not directly measured in this study, may contribute to reduced carbohydrate availability and the body weight loss observed in our LPS-treated mice. In addition, increased catabolic processes, especially in muscle (proteolysis), may lead to reduced lean mass, and hence body weight loss in LPS-treated mice. 85 The reduction in TEE could be attributed to the observed impairment in locomotor activity. GR dim -LPS mice exhibited exaggerated and sustained metabolic alterations relative to WT-LPS mice, suggesting that GR dimerization-dependent DNA-binding mechanisms are required for various metabolic processes to occur under basal conditions and to be kept in check during an immune challenge. Thermoregulation It appears that the GR dimerization-dependent DNA-binding mechanisms that regulate basal metabolism are not required to maintain basal Tc, as the circadian rhythm and amplitude of Tc were similar in the GR dim and WT saline-treated mice. Systemic inflammation is usually accompanied by changes in body temperature, either fever or hypothermia. 16 In addition to glucocorticoids' role in mobilizing energy to facilitate thermogenesis, they also act as antipyretics by blocking the synthesis of pyrogenic cytokines and eicosanoids and by upregulating the transcription of anti-inflammatory molecules. 36, 37, 86 Upon LPS administration, WT mice in our study exhibited an elevation in Tc and a constant skin temperature, whereas GR dim -LPS mice exhibited impaired thermoregulation, as evidenced by their inability to maintain a fever and display of reduced skin temperature relative to WT-LPS mice. In the face of impaired heat production in the GR dim -LPS mice, the observation of reduced skin temperature (because of increased shunting of blood from peripheral tissues to internal organs) and prolonged sickness behaviors, such as piloerection and locomotor impairment, may serve as compensatory mechanisms to reduce heat loss from the body's core. 15 Indeed, although impaired heat production was most apparent within the first 24 h after LPS injection, peak sickness behaviors and reductions in skin temperature occurred in the GR dim -LPS mice at 24 h. These data indicate that GR dimerization-dependent DNA-binding mechanisms are necessary for the proper regulation of inflammation-induced thermoregulatory processes. The observation that GR dim -LPS mice were impaired in their ability to maintain a fever, rather than exhibiting exaggerated fever responses, suggests that the role of GR dimerization-dependent DNA-binding mechanisms in mobilizing energy to facilitate thermogenesis is more prominent than its antipyretic effects. As fever is the result of a balance between pyrogenic and cryogenic mechanisms, the impaired fever observed in the GR dim -LPS mice may also be due to enhanced early expression of cryogenic factors, such as TNFa and IL-10. 86, 87 Moreover, under conditions of impaired gluconeogenesis, and hence deficient energy resources for thermogenesis, a transient state of hypothermia-rather than an energetically costly fevermay be an adaptive mechanism to conserve energy. 19 
CONCLUSION
In summary, GR dim mice are more sensitive to the neuroendocrine, inflammatory, behavioral and metabolic effects of LPS, indicating that GR dimerization-dependent DNA-binding mechanisms are essential for the proper regulation and recovery of multiple physiologic responses to a low-dose endotoxin challenge. These data also support the concept that GR dimerization-independent mechanisms are not sufficient for glucocorticoids to exert their full anti-inflammatory effects. As a consequence, endogenous glucocorticoid responses or exogenous glucocorticoid therapy limited to GR monomer-mediated transcriptional effects, such as proteinprotein interactions, could predispose individuals to prolonged behavioral and metabolic sequelae of an enhanced inflammatory state. These include a continued state of sickness/depressive behaviors, such as lethargy/fatigue, reduced locomotor activity and anorexia and metabolic alterations favoring a sustained catabolic state (especially increased proteolysis in skeletal muscle required for increased gluconeogenesis in the liver), which can lead to muscle wasting, fat gain (cachectic obesity), insulin resistance (selective inhibition of fuel storage in liver, adipose tissue and muscle), osteopenia (reduced calcium absorption in bone) and anemia (reduced iron in blood) to provide sustained fuel to the activated immune system. 13 Therefore, many features traditionally attributed to elevated glucocorticoids could actually be caused by impaired GR function, and hence glucocorticoid resistance and ensuing enhanced inflammation. 5 Indeed, the use of antidepressants has been shown to attenuate multiple aspects of the acute-phase response, including LPS-induced CORT responses, sickness behaviors and hypothermia. 88, 89 These protective effects may be mediated by the antidepressant's ability to increase GR expression/function 90 and reduce proinflammatory cytokine expression/signaling. 9, 12 Genetic and environmental/physiological factors can contribute to impaired GR function. Although it may be unlikely that humans with depression have GR mutations that affect dimerization per se, GR variants have been described that confer reduced GR function. These variants have been associated with reduced dexamethasone suppression of CORT, increased vulnerability to inflammatory conditions/autoimmune diseases and increased risk of depression. 91 Inflammation can also affect GR function. In addition to an enhanced inflammatory state being evident in the medically ill, whether because of infection or noninfectious chronic inflammatory disorders, 7-10 elevated proinflammatory cytokine signaling has also been associated with chronic psychosocial stress. [92] [93] [94] [95] Proinflammatory cytokines have been shown to impair GR function via a variety of mechanisms: (1) reduced expression and/or affinity; (2) reduced translocation from the cytoplasm to the nucleus, which could be affected by its phosphorylation state (via mitogen-activated protein kinase pathways); (3) increased interaction with inflammatory-related transcription factors, such as nuclear factor-kB or activator protein-1 (jun/fos); and (4) increased interaction with the dominant-negative isoform, GRb. 26, 96 Because impaired GR function can contribute to enhanced inflammatory processes and enhanced inflammatory signaling can contribute to impaired GR signaling, a vicious feed-forward cycle perpetuating reduced inhibitory feedback on the HPA axis and inflammatory responses may ensue. Therefore, this bi-directional phenomenon has clinical relevance regarding increased susceptibility to the development of neuroendocrine (HPA axis)-and inflammatoryrelated disorders (including depression) and the development of resistance to glucocorticoid therapy in treating inflammatory conditions.
With regard to chronic stress being a common risk factor for depression and morbidity, both animal and human studies support the role of glucocorticoid resistance as an underlying mechanism in psychosocial stress-associated enhancement of peripheral inflammation, thereby indicating the importance of the anti-inflammatory effects of GR. 92, 95, 97 However, recent animal studies have shown that some psychological stress paradigms and stress levels of glucocorticoids increase central inflammatory responses to a subsequent immune challenge, and that this enhanced inflammation is mediated by GR activation. 98 The importance of the timing of the glucocorticoid surge relative to the immune challenge is supported by the findings that exogenous administration of stress levels of CORT before a systemic LPS challenge enhances proinflammatory cytokine expression and signaling in the brain (and periphery), whereas CORT administration after LPS challenge exerts anti-inflammatory effects. 76, 99 Consistent with this, the sensitizing effect of psychogenic stress on subsequent LPS-induced neuroinflammation has been shown to be mediated through GR-dependent priming of microglia (see Frank et al. 100 and references therein). On the other hand, rats with endogenously higher basal CORT levels exhibit reduced LPS-induced GR upregulation concomitant with increased peripheral and CNS inflammatory responses and reduced CNS antiinflammatory responses relative to rats with lower basal CORT levels, 101 suggesting that impaired GR function may contribute to enhanced inflammatory responses. Similarly, GR dim mice start off with higher basal CORT levels relative to their WT counterparts, and our data indicate that an intact GR is crucial for preventing the overexpression of early LPS-induced central proinflammatory cytokines and sickness behavior. Whereas the aforementioned studies only measured early (2-4 h) LPS-induced cytokine expression, our data are the first to suggest that an intact GR may be important to promote the induction of later central cytokine responses. It is possible that later TNFa responses may be neuroprotective by reducing inflammation and allowing for the recovery of sickness behavior. Therefore, both impaired and enhanced GR function may mediate stress and/or glucocorticoidinduced enhancement of cytokine responses in different contexts of glucocorticoid exposure (type of glucocorticoid, concentration, duration of exposure, timing relative to immune challenge), immune response type, activation state of cells, and tissue/cell specificity. 97, 98, 102, 103 Further studies are needed to identify the molecular mechanisms contributing to the exaggerated inflammation and sustained expression of sickness behavior and metabolic alterations observed in the GR dim -LPS mice. Putative factors include alterations in the central expression of anti-inflammatory molecules, neurotransmitter-related enzymes or metabolites, growth factors and CRH. In addition, future studies should investigate potential changes in metabolic enzymes in metabolically active tissue (gluconeogenic enzymes in the liver, lypolytic enzymes in adipose tissue and proteolytic enzymes in muscle), sympathetic nervous system activity, glucose and insulin levels/sensitivity and the expression/function of GR. By further characterizing the molecular mechanisms by which GR regulates inflammation and its behavioral and metabolic sequelae, our data and future studies can inform the pathophysiology of and potential risk factors for clinical conditions associated with HPA axis dysfunction and prolonged inflammation (for example, autoimmune disease, cardiovascular disease, type II diabetes, metabolic syndrome, osteoporosis, depression, chronic fatigue, fibromyalgia,) and may also explain the high comorbidity between these syndromes. 5, 7, 12, 13, 104 Moreover, these data can better inform the development of glucocorticoid-related therapeutic agents for inflammatory disorders and their downstream correlates. Numerous selective glucocorticoid receptor agonists or dissociated GR ligands are being designed to favor the GR monomer conformation, thereby retaining the anti-inflammatory actions traditionally thought to be associated with GR monomer-mediated transrepression (via protein-protein interactions), and minimizing the metabolic side effects associated with GR dimerization-dependent transactivation (via GR-DNA binding). 46, 48, 105, 106 However, our findings show that GR dimerization-dependent DNA-binding mechanisms are important in keeping peripheral and central inflammation in check. Therefore, when designing dissociative glucocorticoids, one may need to consider the cost/benefit ratio between losing some anti-inflammatory potency (and hence gaining the behavioral consequences) and attenuating other adverse side effects, such as hyperglycemia.
